← All companies

BVS

Bioventus Inc.

BVS Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$13.47

+0.30 +2.28%

Key statistics

from XBRL data in SEC filings

Market cap

$943M

Revenue (TTM)

$576M

Net income (TTM)

$28.5M

EPS (TTM)

$0.41

P/E ratio

32.9

Dividend yield

—

Free cash flow

$72.1M

Cash

$35.8M

Total assets

$651M

Gross margin

68.7%

52-week range

$5.81 – $13.95

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 4, 2026 8-K Regulation FD disclosure May 21, 2026 10-Q Quarter ended 2026-03-28 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Director or officer change Nov 17, 2025 10-Q Quarter ended 2025-09-27 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-28 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 4, 2025 8-K Other events Jul 31, 2025 8-K Shareholder vote results Jun 4, 2025 10-Q Quarter ended 2025-03-29 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Completed an acquisition or disposition; Other events Jan 3, 2025 10-Q Quarter ended 2024-09-28 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Entered a material agreement; Other events Oct 4, 2024 10-Q Quarter ended 2024-06-29 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Other events Jul 19, 2024 8-K Entered a material agreement Jun 21, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-30 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release) Mar 12, 2024 8-K Entered a material agreement Jan 19, 2024 8-K Director or officer change Jan 12, 2024 8-K Director or officer change; Regulation FD disclosure Dec 21, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-07-01 Aug 8, 2023 8-K Results of operations (earnings release) Aug 8, 2023 8-K Director or officer change; Shareholder vote results Jun 9, 2023 8-K Completed an acquisition or disposition; Other events May 26, 2023